(3-BROMO-6-CHLOROPYRIDIN-2-YL)METHANOL, 95.0%, 100g

2-{[1-butyl-5-(trifluoromethyl)-1h-1,3-benzodiazol-2-yl]sulfanyl}acetic acid, 97%, 250mg

(2S)-1-BENZYL 2-METHYL 4-HYDROXYPIPERIDINE-1,2-DICARBOXYLATE, 95.0%, 5g

[2-Bromo-4-(methylsulfonyl)phenyl]hydrazine, 95.0%, 5g

1-Phenylprop-2-en-1-ol, 95.0%, 5g

6-Ethylpyridin-3-amine, 95.0%, 5g

4-Bromo-N-(tert-butyl)-3-(trifluoromethyl)benzenesulfonamide, 95.0%, 1g

2,4,6-Triamino-5-nitrosopyrimidine>98.0%(HPLC)(T)5g

9-Fluorenone, 99.00%, 500g

Methyl 2-(5-amino-2-bromophenyl)propanoate, 5g

1-(Methoxymethoxy)-3,5-bis(trifluoromethyl)-benzene, 98%, 5g

6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine, 95.0%, 1g

Simbolo di avvertenza secondo ISO 7010 Etichetta individuale, Rischio biologico, Lunghezza lato 100 mm, 1 pezzo